Citation Impact
Citing Papers
Ferroptosis: past, present and future
2020 Standout
Ferroptosis: molecular mechanisms and health implications
2020 Standout
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
2017
Obinutuzumab for the First-Line Treatment of Follicular Lymphoma
2017
Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: an open-label, multicentre, randomised, phase 3 non-inferiority trial
2013 Standout
Delivery technologies for cancer immunotherapy
2019 Standout
Inflammation and tumor progression: signaling pathways and targeted intervention
2021 Standout
CAR-T cell therapy: current limitations and potential strategies
2021 Standout
Mitochondria as multifaceted regulators of cell death
2019 Standout
Ferroptosis: mechanisms, biology and role in disease
2021 Standout
Development of therapeutic antibodies for the treatment of diseases
2020 Standout
Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017
Chimeric antigen receptor T-cell therapies for lymphoma
2017
Ipilimumab plus Lenalidomide after Allogeneic and Autologous Stem Cell Transplantation for Patients with Lymphoid Malignancies
2017 StandoutNobel
Chimeric Antigen Receptor Therapy
2018 Standout
Ferroptosis as a target for protection against cardiomyopathy
2019 Standout
Duvelisib for CLL/SLL and follicular non-Hodgkin lymphoma
2019
Parellel inhibition of LH-RH-induced cyclic AMP accumulation and LH and FSH release by LH-RH antagonists in vitro.
1975 StandoutNobel
Works of Keith Dawson being referenced
Early Relapse of Follicular Lymphoma After Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone Defines Patients at High Risk for Death: An Analysis From the National LymphoCare Study
2015
Disease characteristics, treatment patterns, prognosis, outcomes and lymphoma‐related mortality in elderly follicular lymphoma in the United States
2015
Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study
2015
Patterns of delivery of chemoimmunotherapy to patients with follicular lymphoma in the United States: Results of the National LymphoCare Study
2013